boschmain

Ace Inhibitor

Antihistamine

Antiplatelet

Antivival

Aminoglycosides

Beta Blocker

Calcium Antagonist

Cephalosporin

Coenzyme

Diaminopyvimidine

Loop Diuretic

Glucocorticoid

H2 Blocker

Haemostatic/
Fibronolytic

Lincosmide

Macrodile

Penicillin

Phenylacetic acid

Proton Pump Inhibitor

Statin

Quinolones

Untitled Document

IN the Managment of HYPERTEBSION
Corace offer 24 hours Ambulatory Blood Pressure Control with Once daily dose

Even More
Antihypertensive Effect of Corace Evident For 36 Hours

24 hours

12 hours

Proven Susperior to Captopril,Enalapril & Quinapril in 24 hours Blood
Pressure Control

In the Management of HEART FAILURE

Corace Improves Important Parameters in Patients with CHF

Haemodynamic

Echocardiographic

Quality of Life

"Patients treated with lisinopril(Corace) improved significantly on Clinical Haemodynamic,
Echocardiographic and Quality of Life Parameters,with few Adverse Reactions,Good Tolerability and Once Daily Dosing"

Corace Saves Lives in the Managment of Acute MI

11%	Reduction in mortality at 6 weeks when lisinopril(corace)started within 24 hours
70%	"Reduction in total mortality evident within 5 days"

Recommended by AHA | ACC for the Management of Acute MI
"5mg initially,5mg after 24 hrs,10mg after 48 hrs, then 10 mg daily for up to 6 weeks"

In the Management of RENAL COMPLICATIONS OF DIADETES

"Lisinopril (Corace) Reduces Urinary Albumin
Excretion & prevent End Stage Renal Disease in Normotensive NIDDM patients"
"median UAE(Urinary Albumin Excretion) fell on lisinopril(Corace) from 65.5 mcg/min
at baseline to 39.0 mcg/min after 12 months

65.5		30.0
		30.0
	after 12 months.
	(Urinary Albumin Excertion mcg/min)

Long Term Reduction
In Urinary Excretion with lisinopril(Corace)